There is likely not a person on the planet following the publicly-traded cannabis stocks as closely as I do. Sometimes I wonder why I make the effort, as the sector is riddled with management teams that typically range from incompetent to outright fraudulent. At 420 Investor, we kiss so many frogs to find just a handful of princes!
While the pace of better companies entering the publicly-trade space has been disappointingly slow, 2016 will hopefully see significant progress on this front. The industry is starting to see better access to capital, though it still isn't great. We have seen several companies enter the market through S-1 rather than the potentially perilous reverse merger, and new rules may allow companies to find investors more easily, getting around the expense of state registrations and also expanding the market to non-accredited investors through Reg A+. Most importantly, perhaps, is that 2016 will be a banner year for ballot initiatives in November. The cannabis industry is getting stronger and stronger, and the public markets will eventually better represent it/
There is no better resource for staying on top of the publicly-traded stocks and the key dynamics of the industry than 420 Investor. We have coverage on over 350 publicly-traded companies, allowing subscribers to quickly do their own research to determine which ones are worth pursuing. Of course, most aren't, so we focus our coverage on what is now a group of 28 companies that include both the most promising companies as well as those that are actively traded (though not necessarily good companies). For those actively trading the sector, 420 Investor is an essential tool, as there is no service that is able to parse the relevant data and information and distill it to its subscribers in such a timely fashion.
I am not ...
